Long-term health care costs following COVID-19: implications for pandemic preparedness.

ABSTRACT:

Objectives

To estimate excess health care costs in the 12 months following COVID-19 diagnosis.

Study design

Retrospective cohort study using Blue Cross Blue Shield of Rhode Island claims incurred from January 1, 2019, to March 31, 2022, among commercial and Medicare Advantage members.

Methods

Difference-in-differences analyses were used to compare changes in health care spend between the 12 months before (baseline period) and the 12 months after (post period) COVID-19 diagnosis for COVID-19 cases and contemporaneous matched controls without COVID-19.

Results

Overall, there were 7224 commercial and 1630 Medicare Advantage members with a COVID-19 diagnosis on/before March 31, 2021, each with a matched control, yielding a sample of 14,448 commercial and 3260 Medic

SUBMITTER: Chambers LC 

PROVIDER: S-EPMC11457842 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature